[Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke].

S V Kotov V A Borisova E V Slyunkova E V Isakova A V Kiselev A S Kotov

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)

In patients in complex therapy receiving intravenous administration of the drug Ampasse at a dose of 25 mg (5.0 ml) 15 administrations, a statistically significant improvement in cognitive functions was revealed according to MoCA tests, Stroop test, Koos Cubes, when compared with the comparison group. The use of Ampasse increased the effectiveness of cognitive and motor rehabilitation in patients with post-stroke disorders.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
randomized controlled trial
systematic review
peritoneal dialysis
emergency department
patient reported outcomes
mesenchymal stem cells
single cell
cell therapy
patient reported
drug induced